Health & Medicine
-
Merck and Ridgeback Reveal Their Covid-19 Pill Reduces Hospitalization and Death by 50%
A drug that is capable of preventing the worst result of covid-19 may finally come to our rescue anytime soon. On the 1st of October being Friday, pharmaceutical companies Merck and Ridgeback Biotherapeutics publicized the preliminary outcome of a big trial testing out their experimental antiviral medication referred to as molnupiravir.
Latest Research Articles
-
Extreme Heatwaves Can Wipe Out Thousands of Marine Life, Risking Jobs and Supply
-
Common Drug for Depression Can Halt Growth of Cancer Cells in Mice
-
Pharmaceutical Companies Race to Develop COVID-19 Antiviral Pill: Will it Work?
-
Amazon and Apple Among Big Corporations Blocking New US Climate Bill
-
Pregnant Mom Lost Unborn Baby Due to Infection From Pet Cat's Feces
Experts Warn Pet Owners to be Vigilant of Hookworms, a Parasite Immune to All Treatments
-
Man Who Refused Treatment After Getting Bit by Bat Dies From Rabies, Illinois' First Case in 70 Years
-
Gene Editing Among Livestock May Increase Resistance to Diseases
Does Worsening Air Pollution Cause More Intense Thunderstorms? Experts Are Trying to Find Out
Social Inequality Heightened as Climate Change Worsens
-
Mild COVID-19 Conditions Could Affect the Brain and Body from Months After Infection
-
Bats Found in Laos Carry Virus Strikingly Similar to SARS-Cov-2
MOST POPULAR
-
Meet Romulus and Remus: Dire Wolf Pups Resurrected with Ancient DNA, Thanks to Colossal Biosciences
-
Meet The Dire Wolf Trio Remus, Romulus And Khaleesi: How A Texas Lab Revived An Extinct Species
-
Massive New Jersey Wildfire Devastates 8,500 Acres, Threatens Wildlife and Communities Amid Historic Drought
-
Is Yerba Mate Nature's Ozempic? Weighing In Risk Vs. Benefits
-
WATCH: 'Ed the Zebra' Airlifted Home After More than a Week on the Run in Tennessee
